Impact of MGUS and myeloma on skeletal health

G. David Roodman, Matthew T. Drake

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Multiple myeloma (MM) is an incurable plasma cell malignancy that evolves from a premalignant condition termed monoclonal gammopathy of undetermined significance (MGUS). MM is the most frequent cancer that involves the skeleton, with 90% of patients eventually developing bone lesions. Bone involvement causes devastating consequences for MM patients, including pathological fractures that occur in 50%-60% of patients and are present in 20% of patients at diagnosis. These fractures cause severe bone pain and increase mortality risk by 20%. MM increases localized bone resorption and suppresses bone formation, causing purely lytic lesions that usually do not repair. MGUS also affects the skeleton, with MGUS patients having a 1.7-fold increased fracture incidence compared to age-matched controls. In this chapter the mechanisms responsible for the impact of MGUS and MM on the skeleton and therapeutic approaches to prevent and treat MGUS- and MM-induced bone disease are discussed.

Original languageEnglish (US)
Title of host publicationMarcus and Feldman’s Osteoporosis
PublisherElsevier
Pages1421-1437
Number of pages17
ISBN (Electronic)9780128130735
DOIs
StatePublished - Jan 1 2020

Keywords

  • Bone disease
  • Bone pain
  • MGUS
  • MMBD
  • Multiple myeloma

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Impact of MGUS and myeloma on skeletal health'. Together they form a unique fingerprint.

Cite this